Bristol-Myers Squibb Company (BMY)
Pharmaceutical maker, 54% in the U.S.. Read October 2, 2026 from the annual report for the period ending December 31, 2025, filed February 11, 2026. Ranked 31 of the 41 Healthcare companies read so far, by the share within reach now.
Within reach now
18%
End of 2028
41%
Employees, annual report
32,500
Leading staffing pattern
Pharmaceutical and Medicine Manufacturing
Share of the working time within reach, long-run pace, four times in five
- Now18%
- End of 202733%
- End of 202841%
- End of 203044%
What changes for its people by the end of 2028, by its industries' figures
- Stays with people 56%
- Becomes checking a model's work 37%
- Handed over with lighter checks 4%
The filing states approximately 32,500 employees in 43 countries, 54% in the U.S., in one medicines business, so one pattern carries the whole workforce (c).
The figures on this page come from the company's own annual report and from BLS staffing patterns for its industries, never from a roster. They are estimates with a stated method. Nothing here says what the company will do: within reach is not a forecast of jobs lost or of savings.
What follows from the reading
Share of working time within reach of AI, on the long-run pace at four in five: 18% now, 33% at the end of 2027, 41% at the end of 2028, 44% at the end of 2030. By the patterns, the work is about 44% desk work, 14% people work and 42% body work. These are the site's industry estimates weighted by the shares below: estimates with a stated method and range, not a forecast of what the company will do. By the same patterns, at the end of 2028 about 56% of the working time stays with people (conversation, in-person and hands-on work), 37% becomes checking a model's work and 4% could be handed over with lighter checks, from the industries' own figures, not the company's roles.
Headcount
32,500 employees as of December 31, 2025 (stated). Approximately 54% of employees are located in the U.S., excluding Puerto Rico, and 46% outside.
The filing: “Demographics : As of December 31, 2025, we had approximately 32,500 employees in 43 countries.”
The workforce as industry patterns
| Pattern | Share | Reason, from the filing |
|---|---|---|
| Pharmaceutical and Medicine Manufacturing | 100% | Discovering, making and selling medicines (NAICS 3254, the SIC 2834 business), one business across 43 countries; the filing counts no employees by function, so one pattern by description (c). |
What the filing says about the workforce: Approximately 32,500 employees in 43 countries, 54% in the U.S.; the workforce is supplemented with contingent and temporary workers and independent contractors, who are not counted.
Companies read with the same leading pattern
Other companies whose largest staffing pattern is also Pharmaceutical and Medicine Manufacturing, largest first, each read from its own annual report. Within reach now and at the end of 2028, long-run pace, four in five.
- Johnson & Johnson (JNJ, 140,800 employees)18% now, 39% by 2028
- Thermo Fisher Scientific Inc. (TMO, 125,000 employees)19% now, 49% by 2028
- Merck & Co., Inc. (MRK, 75,000 employees)18% now, 41% by 2028
- Pfizer Inc. (PFE, 75,000 employees)18% now, 41% by 2028
- AbbVie Inc. (ABBV, 57,000 employees)18% now, 41% by 2028
- Eli Lilly and Company (LLY, 50,000 employees)18% now, 41% by 2028
- Amgen Inc. (AMGN, 31,500 employees)18% now, 41% by 2028
- Viatris Inc. (VTRS, 30,000 employees)18% now, 41% by 2028
What the filing says about AI
10 sentences in the filing name AI. The filing says it is investing in upskilling its workforce in the proper use of AI tools, and names artificial intelligence programs among the information technology systems it depends on and must protect.
- “Recognizing the transformative role of AI across industries, we are investing in upskilling our workforce to build confidence in the proper use and innovative application of these next-generation tools.”
- “These laws and regulations control and regulate key aspects of our business, including, but not limited to: (i) market access, pricing controls and discounting; (ii) tax liabilities, returns and payments; (iii) imports and other trade restrictions; (iv) intellectual property protection and enforcement; (v) good practice guidelines and regulations; (vi) accounting standards; (vii) cybersecurity...”
- “Information Technology and Cybersecurity Risks We are dependent on information technology systems, including artificial intelligence programs, and face risk of cybersecurity incidents that could disrupt our business and result in theft of proprietary, confidential and personal information.”
- “A significant breakdown, invasion, corruption, destruction or interruption of critical information technology systems, including artificial intelligence programs that we utilize, or leak, theft or misuse of proprietary, confidential or personal information could negatively impact operations.”
- “In addition, we face certain risks as we seek to leverage artificial intelligence programs and machine learning ("AI") to optimize productivity and efficiency in various aspects of the organization.”
Its annual reports, year by year
Sentences naming AI in each annual report, counted by one rule, beside the median report in the Index that year. Each count links its filing. Every company, by year and sector
- Fiscal 20210median 0
- Fiscal 20220median 0
- Fiscal 20230median 1
- Fiscal 20246median 4
- Fiscal 202510median 10
Headcount by filing year
As reported in each year's annual report, with the filing. A year marked not read had no figure the reading could take from the report's text.
| Period | Employees | Filed | Filing |
|---|---|---|---|
| 2025-12-31 | 32,500 | 2026-02-11 | 10-K |
| 2024-12-31 | 34,100 | 2025-02-12 | 10-K |
| 2023-12-31 | 34,100 | 2024-02-13 | 10-K |
| 2022-12-31 | 34,300 | 2023-02-14 | 10-K |
| 2021-12-31 | 32,200 | 2022-02-09 | 10-K |
| 2020-12-31 | 30,250 | 2021-02-10 | 10-K |
| 2019-12-31 | 30,000 | 2020-02-24 | 10-K |
| 2018-12-31 | 23,300 | 2019-02-25 | 10-K |
| 2017-12-31 | 23,700 | 2018-02-13 | 10-K |
| 2016-12-31 | 25,000 | 2017-02-21 | 10-K |
| 2015-12-31 | 25,000 | 2016-02-12 | 10-K |
| 2014-12-31 | 25,000 | 2015-02-13 | 10-K |
| 2013-12-31 | 28,000 | 2014-02-14 | 10-K |
| 2012-12-31 | 28,000 | 2013-02-15 | 10-K |
| 2011-12-31 | 27,000 | 2012-02-17 | 10-K |
| 2010-12-31 | 27,000 | 2011-02-18 | 10-K |
| 2009-12-31 | 28,000 | 2010-02-19 | 10-K |
| 2008-12-31 | 35,000 | 2009-02-20 | 10-K |
| 2007-12-31 | 42,000 | 2008-02-22 | 10-K |
| 2006-12-31 | 43,000 | 2007-02-26 | 10-K |
| 2005-12-31 | 43,000 | 2006-03-14 | 10-K |
| 2004-12-31 | 43,000 | 2005-03-04 | 10-K |
| 2003-12-31 | 44,000 | 2004-03-15 | 10-K |
| 2002-12-31 | 44,000 | 2003-03-28 | 10-K |
| 2001-12-31 | 46,000 | 2002-04-01 | 10-K405 |
| 2000-12-31 | 44,000 | 2001-04-02 | 10-K |
| 1999-12-31 | 54,500 | 2000-03-30 | 10-K |
| 1998-12-31 | 54,700 | 1999-03-30 | 10-K |
| 1997-12-31 | 53,600 | 1998-03-31 | 10-K |
| 1996-12-31 | 51,200 | 1997-03-31 | 10-K |
| 1995-12-31 | 49,140 | 1996-03-28 | 10-K |
| 1994-12-31 | 47,700 | 1995-03-29 | 10-K |
| 1993-12-31 | 49,500 | 1994-03-31 | 10-K |
Limits of this reading
- One pattern by description (c): the filing counts no employees by function.
Source: the company's annual report on EDGAR, accession 0000014272-26-000004, the filing. Read by Claude Fable 5.1 under rubric version 1, by the method. A company can write to info@stratussc.com to have its reading checked against its filing.
Questions about this company
- How much of Bristol-Myers Squibb Company's working time is within reach of AI?
- An estimated 18% now and 41% by the end of 2028, on METR's long-run pace at four in five, from the workforce Bristol-Myers Squibb Company's own annual report describes and BLS staffing patterns for its industries, never from a roster. It is an estimate with a stated method. It is not a forecast of jobs lost or of savings, and it says nothing about what the company will do.
- How many people does Bristol-Myers Squibb Company employ?
- 32,500 as of December 31, 2025, as its annual report for the period ending December 31, 2025 states. About 54% in the U.S.
- What kinds of work make up Bristol-Myers Squibb Company's workforce?
- Read from its annual report as a blend of 1 industry staffing pattern, the largest Pharmaceutical and Medicine Manufacturing; by those patterns the work is about 44% desk work, 14% people work and 42% body work. Each share has a one-sentence reason on this page that can be checked against the filing.
- What does Bristol-Myers Squibb Company's annual report say about AI?
- 10 sentences in the filing name AI. Its annual reports for fiscal 2021 to 2025 name it in 0, 0, 0, 6 and 10 sentences, year by year. They are counted and quoted on this page, never judged: a count says how much a filing talks about AI, not what the company does with it.
- How is this estimated?
- Claude Fable 5.1 read the annual report under the Index's written rubric (version 1) on October 2, 2026: the stated headcount, the share in the U.S. when stated, and the workforce as a blend of industry staffing patterns. The estimates are the site's industry estimates weighted by those shares, from O*NET tasks with estimated lengths and METR's measurements of how long a task AI models can finish. A company can write to info@stratussc.com to have its reading checked against its filing.
Embed these figures on your site
A small card with the share of working time within reach now and at the end of 2027, 2028 and 2030, the date and a link back. Free under CC BY 4.0; the card carries the credit.